Literature DB >> 2165091

Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats.

J L Paquet1, M Baudouin-Legros, G Brunelle, P Meyer.   

Abstract

In order to determine whether the morphological modifications observed in arterial media of spontaneously hypertensive rats (SHR) could be induced by an abnormal response of the smooth muscle cells to vasoactive agents, we studied the action of angiotensin (Ang) II on cultured aortic smooth muscle cells from both SHR and Wistar-Kyoto rats (WKY). Under our experimental conditions, Ang II exerts a mitogenic action on SHR cells, whereas its effect is very weak on WKY cells. Phospholipase C activation and c-fos and c-myc proto-oncogene expressions induced by Ang II are considerably enhanced in SHR cells, and these abnormalities may be linked to an increased number of Ang II receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165091     DOI: 10.1097/00004872-199006000-00010

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  17 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

2.  N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane.

Authors:  B Deslauriers; C Ponce; C Lombard; R Larguier; J C Bonnafous; J Marie
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.

Authors:  B I Levy; J Benessiano; D Henrion; L Caputo; C Heymes; M Duriez; P Poitevin; J L Samuel
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptors.

Authors:  Rajendra Kumari; Gareth Goh; Leong L Ng; Michael R Boarder
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

5.  Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.

Authors:  Denise M Boudreau; Onchee Yu; Jessica Chubak; Heidi S Wirtz; Erin J Aiello Bowles; Monica Fujii; Diana S M Buist
Journal:  Breast Cancer Res Treat       Date:  2014-02-21       Impact factor: 4.872

6.  Novel and effective gene transfer technique for study of vascular renin angiotensin system.

Authors:  R Morishita; G H Gibbons; Y Kaneda; T Ogihara; V J Dzau
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis.

Authors:  Yan Huang; Annarita Di Lorenzo; Weidong Jiang; Anna Cantalupo; William C Sessa; Frank J Giordano
Journal:  Hypertension       Date:  2013-08-05       Impact factor: 10.190

8.  Dose-dependent effects of angiotensin converting enzyme (ACE) inhibitors on glomerular prostanoid production by normotensive rats.

Authors:  P Harding; C Stonier; G M Aber
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

9.  Stimulation of two vascular smooth muscle-derived cell lines by angiotensin II: differential second messenger responses leading to mitogenesis.

Authors:  C Morton; R Baines; I Masood; L Ng; M R Boarder
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

10.  Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.

Authors:  V Briand; L Riva; A M Galzin
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.